Treatment outcomes of secukinumab in adult patients with moderate‐to‐severe plaque psoriasis in China: A real‐world multicenter retrospective study

Secukinumab is effective in treating patients with moderate‐to‐severe plaque psoriasis. However, most studies assessing its effectiveness in routine clinical settings in China are mostly single‐center studies with a limited sample size. The objective of this study was to assess secukinumab's ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Yangfeng, Li, Wei, Guan, Xin, Liu, Na, Zhou, Ying, Li, Gaojie, Wang, Xiaohua, Wang, Zhidong, Xiao, Xiao, Yang, Bin, Lv, Chengzhi, Zhang, Chunlei, Shi, Yuling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582683/
https://www.ncbi.nlm.nih.gov/pubmed/37644777
http://dx.doi.org/10.1111/cts.13583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582683/
https://www.ncbi.nlm.nih.gov/pubmed/37644777
http://dx.doi.org/10.1111/cts.13583

Ejemplares similares